Key facts
- It has raised $25.3M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Innovate UK, Texas Medical Center, Mercia Ventures, IQ Capital Partners, Mercia Asset Management — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Optellum
- ·The full record, as it builds
Funding rounds
No funding rounds for Optellum are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Optellum
Developer of a clinical software designed to diagnose lung cancer and treat it at an early stage. The company's software identifies at-risk patients and expedites optimal therapy for patients with cancer as well as captures patients with incidental nodules through automated analysis of radiology reports, enabling physicians to manage their patients in an optimal way.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2015
- Employees
- 50
- Website
- optellum.com/
- Ownership
- Privately Held (backing)
Optellum doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optellum shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optellum in its N-PORT filings yet. We sweep new filings monthly.